Please use this identifier to cite or link to this item:
|Title:||Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.||Austin Authors:||Admojo, Lorenztino;Korte, James;Anderson, Nigel;Phillips, Claire;Caspersz, Lauren;Lasocki, Arian||Affiliation:||Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
|Issue Date:||17-Jan-2023||metadata.dc.date:||2023||Publication information:||Journal of Medical Imaging and Radiation Oncology 2023; 67(3)||Abstract:||The incidence of radionecrosis (RN) after stereotactic radiosurgery (SRS) to brain metastases is increasing. An overlap in the conventional MRI appearances of RN and tumour recurrence (TR) is diagnostically challenging. Delayed contrast MRI compares contrast enhancement over two time periods to create treatment response assessment maps (TRAMs). We aim to assess the utility of TRAMs in brain metastases patients.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/32019||DOI:||10.1111/1754-9485.13504||ORCID:||0000-0002-3674-6205
|Journal:||Journal of Medical Imaging and Radiation Oncology||PubMed URL:||36650724||ISSN:||1754-9485||Type:||Journal Article||Subjects:||brain metastases
delayed contrast MRI
treatment response assessment maps
|Appears in Collections:||Journal articles|
Show full item record
checked on Jun 8, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.